基于干细胞治疗的干预措施:目前的进展和未来的承诺
Dinesh Kumar1, Mehboob's Ashraf2, Vrinda Gupta3
1GNA School of Pharmacy, GNA University, Phagwara, Punjab, India.
Epileptic disorders : international epilepsy journal with videotape
|November 7, 2025
概括
干细胞疗法显示,通过修复脑损伤和恢复神经平衡来治疗耐药性有前途. 早期试验表明安全性和控制的潜力,为耐传统治疗的患者提供希望.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 的研究研究.
背景情况:
- 影响着全球数以百万计的人,许多患者对当前的治疗反应不佳.
- 由于神经网络受损和炎症,耐火性带来了重大挑战.
- 干细胞疗法提供了一种新的再生方法来解决这些潜在问题.
研究的目的:
- 审查干细胞治疗耐火性的潜力.
- 总结临床前和早期临床发现.
- 讨论该领域的未来方向和挑战.
主要方法:
- 对使用各种模型 (皮洛卡尔,酸,燃烧) 的临床前研究的审查.
- 对各种干细胞类型 (胚胎,神经,iPSC,MSC) 的分析.
- 评估早期临床试验数据的安全性,可行性和有效性.
主要成果:
- 临床前模型显示发作减少,认知增强和移植后组织学修复.
- 不同的干细胞类型显示出独特的治疗潜力和挑战.
- 早期的临床试验表明安全性,可行性,以及对控制和生活质量的积极趋势.
结论:
- 干细胞疗法是耐火性的有前途的再生治疗方法.
- 目前正在进行的基因编辑和外体治疗等创新旨在克服翻译障碍.
- 个性化的方法,监管标准和经济模型对于临床进步至关重要.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Embryonic Stem Cells
4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Embryonic Stem Cells
32.0K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.0K
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K


